Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
Authors:
- Stefan FruehaufSFStefan Fruehauf
- Julian TopalyJTJulian Topaly
- Eike C BussEBEike C Buss
- Moritz SchadMSMoritz Schad
- Martin GoernerMGMartin Goerner
- W Jens ZellerWZW Jens Zeller
- Anthony D HoAnthony D Ho
- 1 December 2002
- journal article
- case report
- Vol. 87 (12) , ECR38